Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 12/20 | 0.41 |
| ▸ | KDM5A | P29375 | 2/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5359782 | 0.88 | CHRM2 (0.41) | ACHEEPHX2SMN1; SMN2 | |
| SCHEMBL17117556 | 0.80 | ACHE (0.44) | ACHE | |
| SCHEMBL13092685 | 0.79 | DNM1 (0.48) | ACHEEPHX1 | |
| SCHEMBL30872097 | 0.77 | EPHX1 (0.45) | ACHEEPHX1 | |
| SCHEMBL8084072 | 0.77 | EPHX2 (0.41) | ACHEEPHX2 | |
| SCHEMBL1801127 | 0.77 | CHRM2 (0.38) | ACHESMN1; SMN2EPHX1 | |
| SCHEMBL27812694 | 0.76 | EPHX1 (0.44) | ACHEEPHX1 | |
| SCHEMBL9506389 | 0.76 | KDM5A (0.40) | KDM5APHF8KDM4CEPHX2 | |
| SCHEMBL7179665 | 0.75 | EPHX1 (0.49) | ACHEEPHX2NPC1RAB9ASMN1; SMN2 | |
| Trolamine SCHEMBL27175300 | 0.75 | EPHX2 (0.41) | KDM5APHF8KDM4CEPHX2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11174235-B2 | Carboxy alkyl-ester anti-agglomerants for the control of natural gas hydrates | CHAMPIONX USA INC. (US) | 2021-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11174235-B2 | Carboxy alkyl-ester anti-agglomerants for the control of natural gas hydrates | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AQP1, AQP3 | ACHE 923/4885KDM5A 2954/4885PHF8 875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.